Advanced Instruments Exhibits New Products and Technologies at AACC
|
By LabMedica International staff writers Posted on 31 Jul 2018 |
|
Image: The Osmo1 single-sample micro-osmometer (Photo courtesy of Advanced Instruments).
Advanced Instruments (Norwood, MA, USA) exhibited its new Osmo1 single-sample micro-osmometer, alongside its full line of instrumentation for clinical laboratories, including the Anoxomat III jar system and GloCyte automated cell counter system, at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo. Advanced Instruments, a developer of scientific and analytical instruments for the clinical industry, provides solutions and support to the clinical laboratory market.
The new Osmo1 single-sample micro-osmometer can measure the osmolality of specimens, including urine, serum, plasma, stool, and other body fluids, and uses a small 20 μL sample size. It offers workflow efficiency, result security and integrity, connectivity, quality control, and audit control for today’s busy clinical laboratories.
The Anoxomat III is an easy-to-use jar system for microbiology laboratories with the ability to create anaerobic, microaerophilic, and custom environments – such as capnophilic – within a few minutes. The quality control process checks the jar to ensure that there is no leakage and the catalyst is working, and provides the end user with documentation that the jar is under the appropriate environment before the incubation starts. The Anoxomat system offers shorter test times, improved workflow, and reduced operational costs for laboratories.
The GloCyte automated cell counter system combines fluorescence and imaging technology to deliver highly accurate and precise counts of total nucleated cells (TNCs) and red blood cells (RBCs) in cerebrospinal fluid samples. It is the only system that is linear down to 0 cells/μL and has a limit of detection of 1 cell/μL for both RBC and TNC. The GloCyte system requires a small sample volume of only 30 micro liters per test, minimizes manual errors with LIS connectivity, and features a built in quality control system that ensures accurate and precise results.
"Advanced Instruments is committed to supporting patient care by providing innovative technologies that meet the needs of clinical laboratories while helping improve workflow efficiencies," said Byron Selman, CEO of Advanced Instruments. "We look forward to introducing lab techs, managers, and directors to the new products in our portfolio that can contribute to their future success."
The new Osmo1 single-sample micro-osmometer can measure the osmolality of specimens, including urine, serum, plasma, stool, and other body fluids, and uses a small 20 μL sample size. It offers workflow efficiency, result security and integrity, connectivity, quality control, and audit control for today’s busy clinical laboratories.
The Anoxomat III is an easy-to-use jar system for microbiology laboratories with the ability to create anaerobic, microaerophilic, and custom environments – such as capnophilic – within a few minutes. The quality control process checks the jar to ensure that there is no leakage and the catalyst is working, and provides the end user with documentation that the jar is under the appropriate environment before the incubation starts. The Anoxomat system offers shorter test times, improved workflow, and reduced operational costs for laboratories.
The GloCyte automated cell counter system combines fluorescence and imaging technology to deliver highly accurate and precise counts of total nucleated cells (TNCs) and red blood cells (RBCs) in cerebrospinal fluid samples. It is the only system that is linear down to 0 cells/μL and has a limit of detection of 1 cell/μL for both RBC and TNC. The GloCyte system requires a small sample volume of only 30 micro liters per test, minimizes manual errors with LIS connectivity, and features a built in quality control system that ensures accurate and precise results.
"Advanced Instruments is committed to supporting patient care by providing innovative technologies that meet the needs of clinical laboratories while helping improve workflow efficiencies," said Byron Selman, CEO of Advanced Instruments. "We look forward to introducing lab techs, managers, and directors to the new products in our portfolio that can contribute to their future success."
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
Latest AACC 2018 News
- Mesa Biotech Showcases PCR Testing Platform at Clinical Expo
- Mindray Medical Unveils Chemiluminescence Immunoassay System at AACC 2018
- Abbott Diagnostics Displays Alinity Family of Systems
- Roche Diagnostics Highlights Latest Clinical Lab Solutions at AACC
- Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology
- Ortho Clinical Diagnostics Unveils Next-Gen Analyzer at Lab Show
- Snibe Diagnostic Presents Immunoassay Systems and Biochemistry Analyzers
- Thermo Fisher Scientific Showcases Product Portfolio at Lab Trade Show
- EKF Diagnostics Highlights Assay Kit and POC Analyzer at AACC 2018
- Randox Laboratories Showcases Advances in Biotechnology at Clinical Lab Expo
- Beckman Coulter Life Sciences Highlights Clinical Flow Cytometry Portfolio
- Beckman Coulter Features New Hematology Analyzers and Lab Automation
- Carolina Liquid Chemistries Promotes Family of Clinical Chemistry Analyzers
- Orion Diagnostica Showcases Rapid Test and Molecular Platform at Lab Show
- Saladax Biomedical Launches Game-Changing Assays at AACC 2018
- SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo
Channels
Clinical Chemistry
view channel
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
Technology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
